Antibodies News and Research

RSS

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.

18 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

Wisconsin has identified its first laboratory confirmed case of influenza this season

Public health officials in the department said the case, confirmed by the Wisconsin State Laboratory of Hygiene to be influenza type A (H3 subtype), involves an adult female from Waupaca County.

13 Oct 2004

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

MedImmune has announced that data from a preclinical study for its lead vaccine candidate to prevent respiratory syncytial virus (RSV) and parainfluenza virus type-3 (PIV-3) has shown a protective immune response against both viruses in animals.

13 Oct 2004

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Flu shots have been around since World War II, and the Centers for Disease Control and Prevention has long recommended shots as a way to prevent influenza in the elderly. The approval of a new nasal spray vaccine begs the question whether those looking to stave off the flu should stick with the tried and true injection or switch to the nasal spray.

13 Oct 2004

Researchers have identified a protein in the inner ear that translates sound into the nerve impulses used by the brain

Researchers at Harvard Medical School and their colleagues report in the October 13 Nature advanced on-line edition that they have identified a protein deep in the inner ear that they believe translates sound into the nerve impulses used by the brain.

13 Oct 2004

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

A protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain by transporting this agent back into the bloodstream, thus reducing the ability of this agent to reach tumors.

11 Oct 2004

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.

11 Oct 2004

Researchers suggest how to generate B cells from stem cells

Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.

11 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

$10 million to establish a multidisciplinary research program in cancer nanotechnology

The National Institutes of Health (NIH) has awarded scientists from Emory University and the Georgia Institute of Technology two new collaborative research grants, totaling nearly $10 million, to establish a multidisciplinary research program in cancer nanotechnology and to develop a new class of nanoparticles for molecular and cellular imaging.

6 Oct 2004

Cancer vaccine based on listeria bacteria shows promise

An experimental cancer vaccine using defanged listeria bacteria is showing great promise in animal studies, successfully treating new cancers that have spread into the lungs of mice.

29 Sep 2004

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

Researchers first gave the drug, mannitol, to provide temporary passage through the blood-brain barrier then transfused human umbilical cord blood cells into a stroke animal model. When used in the first hours and days following a stroke, stroke size decreased by 40 percent and resulting disability was significantly reduced.

26 Sep 2004

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

Elan and Wyeth receive patents for Alzheimer's disease treatments

Elan Corporation and Wyeth Pharmaceuticals have announced that the United States Patent and Trademark Office recently issued Neuralab Limited, a subsidiary of Elan, seven patents for the companies’ joint research on immunotherapeutic approaches to the prevention and treatment of Alzheimer’s disease.

23 Sep 2004

New gene therapy technique may help treat Alzheimer's disease

Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.

21 Sep 2004

Antibodies News and Research

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Malaria vaccine candidate looks extremely promising

Wisconsin has identified its first laboratory confirmed case of influenza this season

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Researchers have identified a protein in the inner ear that translates sound into the nerve impulses used by the brain

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

Researchers suggest how to generate B cells from stem cells

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

$10 million to establish a multidisciplinary research program in cancer nanotechnology

Cancer vaccine based on listeria bacteria shows promise

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Elan and Wyeth receive patents for Alzheimer's disease treatments

New gene therapy technique may help treat Alzheimer's disease

Stress response proteins offer a promising target for a novel drug guidance system

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

Neck surgeons brush up on West Nile virus

The same gene functions in vision and immune system, research shows

Immunology eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News